-
Heather Jaspan MD/PhD
Fellow
Email: heather.jaspan@seattlechildrens.org
Undergraduate
University of North Carolina, Chapel Hill, Biology, 1992, Magna Cum Laude
Medical School
Tulane University, MD, PhD, 1999
Residency
Children's Hospital and Regional Medical Center/University of Washington, 1999-2002
HB Jaspan and WA Hanekom. Immunology of infants through adolescents: Responses to emulate for HIV vaccines. Current Opinions in HIV and AIDS 2007, 2:391-398.
Kafaar Z, Swartz L, Kagee A, Lesch A, Jaspan H. Adolescent participation in HIV vaccine trials: cognitive developmental considerations. SAJP. In Press.
HB Jaspan, AJ Flisher, L Myer, et al. Brief Report: Methods for collecting sexual behaviour information from South African adolescents - a comparison of paper versus personal digital assistant questionnaires. J Adolesc. 2007:30(2);353-9.
HB Jaspan, JR Berwick, L Myer, C Mathews, AJ Flisher, R Wood, and LG Bekker. Adolescent HIV Prevalence, Sexual Risk, and Willingness to Participate in HIV Vaccine Trials. J Adolesc Health. 2006 39(5) 642-8.
HB Jaspan, SD. Lawn, JT. Safrit, and LG Bekker. The maturing immune system: implications for development and testing HIV-1 vaccines for children and adolescents. AIDS. 2006. 20:483-494.
LG Bekker, H Jaspan, J McIntyre, R Wood, and G Gray. Adolescents and HIV Vaccine trials: what are the clinical trial site issues? JIAPAC. 2005; 4(4);93-7.
HB Jaspan, LG Bekker, CJ Grant, CA Slack, AE Strode and JR Berwick. Protecting South Africa’s children from HIV; giving them our best shot. SAJS, 2005;101: 216-17.
HB Jaspan, G Gray, A Robinson, H Coovadia and LG Bekker. The scientific justification for the participation of children and adolescents in HIV-1 Vaccine Trials in South Africa. SAMJ. 95(9) 685-7.
HB Jaspan, JJC Nuttall and BS Eley. Paediatric Antiretroviral Therapy for the General Practitioner. CME. 2005;23(4): 222-228.
Jaspan, HB, Robinson, JE, Amedee, AM, Nicholson, S, Van Dyke, RB, Bielke, MA and Garry, RF. Neutralizing antibody to lentiviruses in amniotic fluid. Journal of Clinical Virology, 2004 Nov;31(3):190-7.
Heather B. Jaspan and Robert F. Garry. Preventing Neonatal HIV: A Review. Current HIV Research. 2003, 1(3), 321-327
Jaspan, Heather B, Gaumer, Richard, and Garry, Robert F. Quantitative Competitive Reverse Transcription Polymerase Chain Reaction is not a useful method for quantitation of CD4 and CD8 cell status during HIV infection. JNRBM. 2003 Mar 12;2(1):2.
Jaspan, HB, Gaumer, R, Chiang, C-F, and Garry, RF. Expression of Granzyme B mRNA is altered in human immunodeficiency virus infected individuals. Journal of Molecular Pathology. 2003. Feb; 74(1):13-16
Selected Abstracts
H Jaspan, A Berrisford, P Roux, and A Boulle. Outcomes Of Children on Non-nucleoside Reverse Transcriptase Inhibitor Versus Protease Inhibitor Highly Active Antiretroviral Regimens in Resource-Limited Settings, CROI February 25-18, 2007, Los Angeles, CA, Abstract # R156
Jaspan HB, Mark D, Myer L, et al. Recruitment and Sexual Risk Assessment of HIV Negative Adolescents Aged 14 to 17 Years in Preparation for HIV Vaccine Trials. CROI February 25-18, 2007, Los Angeles, CA, Abstract # R169
N Soka, H Jaspan, C Mathews, AJ Flisher, R Wood, and LG Bekker. Prospects and challenges of involving adolescents in future HIV vaccine trials. The case of Nyanga district youth (14-17 years) in Cape Town, South Africa. XVI International AIDS Conference, 13-18 August 2006, Toronto, Canada.
Muller AD, Myer L, Jaspan HB, Bode S, Roux P, and v Steinbuchel N. Innovative use of electronic measurement for adherence to liquid antiretrovirals in an urban South African paediatric clinic. Priorities in AIDS Care & Treatment, October 3-5, 2006, Cape Town, SA
C Morgan, R Bailer, B Metch, R Koup, R Paranjape, E Vardas, J Pape, J P Figueroa, P Barroso, A Kalichman, H Jaspan, C Metcalf, J Lama, N Jack, and N Russell. International Seroprevalence of Neutralizing Antibodies against Adenovirus. AIDS Vaccine 2005 International Conference. Montreal, Canada, September 2005
Jaspan HB, Berwick JR, Mathews C, Myer L, Flisher AJ, Seebregts C, and Bekker L-G.
Feasibility of HIV vaccine efficacy trials in South African Adolescents. 3rd IAS Conference on HIV Pathogenesis and Treatment, Rio, Brazil, July 2005.
Strode A, Grant C, Jaspan H, Slack C, Smit T, Mushariwa M, Barsdorf N. Developing a legislative framework to protect child research participants in South Africa. 2nd South African AIDS conference, Durban South Africa, June 2005
© 2007-2009 Seattle Children's Hospital, Research & Foundation